ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer.

ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer. Abstract Text:

Bon-Hun Koo,Tiina Hurskainen,Katrina Mielke,Phyu Phyu Aung,Graham Casey,Helena Autio-Harmainen,Suneel S Apte,

ADAMTSL3/punctin-2 is a secreted glycoprotein that resembles the ADAMTS proteases. Recently, identification of frequent ADAMTSL3 mutations in colorectal cancer suggested it might have a regulatory role in cellular homeostasis in colorectal epithelium or in pathways to colorectal malignancy. Here, we used in situ hybridization to validate ADAMTSL3 antibodies for IHC of a variety of normal and malignant tissues, including colon cancer. Quantitative real-time PCR (RTQ-PCR) was used to compare mRNA expression levels in colon carcinoma (n = 10) and adjacent normal colon. ADAMTSL3 is expressed in epithelial cells of the colon, fallopian tube, skin, breast, prostate, epididymis, liver, pancreatic islets and bile ducts, as well as by vascular endothelial cells, smooth muscle cells, fibroblasts, cortical and ganglionic neurons and cardiac myocytes. Malignant epithelial cells in colon cancer, as well as breast, prostate, renal and skin tumors expressed ADAMTSL3. Normal colon showed stronger immunostaining of surface than basal crypt epithelium and staining of a variety of cells within the lamina propria and submucosa. Colon carcinomas demonstrated weaker staining in tumor cells than normal colon epithelium and weak stromal staining. RTQ-PCR comparison of ADAMTSL3 mRNA in colon carcinoma and adjacent normal colon demonstrated a statistically significant reduction in the tumors, possibly reflecting their decreased stromal content and lack of complete differentiation of tumor samples. The major findings of these studies are that ADAMTSL3 is expressed in numerous tissues, suggesting a broader regulatory role than in colorectal epithelium alone, and that colorectal cancer has both structural mutations as well as decreased expression of ADAMTSL3.

ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer. Publishing Authors By Initials

BH Koo,T Hurskainen,K Mielke,PP Aung,G Casey,H Autio-Harmainen,SS Apte,

For similar investigative techniques: clinical laboratory techniques: culture techniques: tissue culture techniques research abstracts see: investigative techniques: clinical laboratory techniques: culture techniques: tissue culture techniques research

PUBMED ID PMID:

MEDLINE DATE:

ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: International journal of cancer. Journal internati

VOLUME: 121

Page Numbers: 1710-6

Journal Abbreviation: Int. J. Cancer

ISSN: 0020-7136

DAY: 15

MONTH: Oct

YEAR: 2007

ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 42124

ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer. Keywords Mesh Terms:

KEYWORDS: Tissue Culture Techniques

MESH TERMS: metabolism

Chemical & Substance for Abstract: ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer. Information

Substance Name: RNA, Messenger

Registry Number: 0

Grant and Affiliation Information for ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer.

AFFILIATION: Department of Biomedical Engineering, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

Country: United States

AGENCY: United States NIAMS

GRANT: AR50953

ACRONYM: AR

MEDLINETA: Int J Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer Related Publications

• A novel potassium deficiency-induced stimulon in Anabaena torulosa.
• A novel serralysin metalloprotease from Deinococcus radiodurans.
• ADAMTS-like 2 (ADAMTSL2) is a secreted glycoprotein that is widely expressed during mouse embryogenesis and is regulated during skeletal myogenesis.
• ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer.
• Air filter materials, outdoor ozone and building-related symptoms in the BASE study.
• An assay for macrophage-mediated regulation of endothelial cell proliferation.
• An integrative expression vector for strain improvement and environmental applications of the nitrogen fixing cyanobacterium, Anabaena sp. strain PCC7120.
• Angiogenesis in eye disease: immunity gained or immunity lost?
• Blood substitutes- the polyheme trials.
• Characterization of a response regulator protein that binds to Anabaena sp. strain L-31 kdp-promoter region.
• Cloning and overexpression of alkaline phosphatase PhoK from Sphingomonas sp. strain BSAR-1 for bioprecipitation of uranium from alkaline solutions.
• Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.
• Comparative in vitro study of six carbamazepine products.
• Effect of senescence on macrophage polarization and angiogenesis.
• Interleukin-10 Promotes Pathological Angiogenesis by Regulating Macrophage Response to Hypoxia during Development.
• Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.
• Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to angioid streaks.
• Intravitreal pharmacotherapy: applications in retinal disease.
• Molecular mechanisms of pancreatitis: Current opinion.
• Nitrogen status and heat-stress-dependent differential expression of the cpn60 chaperonin gene influences thermotolerance in the cyanobacterium Anabaena.
• O-fucosylation of thrombospondin type 1 repeats in ADAMTS-like-1/punctin-1 regulates secretion: implications for the ADAMTS superfamily.
• Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance.
• Pancreatic stellate cells: partners in crime with pancreatic cancer cells.
• Pegaptanib sodium for the treatment of age-related macular degeneration.
• Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice.